Neuromedical Core (Page 348)
神经医学核心(第348页)
基本信息
- 批准号:8195002
- 负责人:
- 金额:$ 35.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AIDS neuropathyAcuteAddressAgeAgingAliquotAlzheimer&aposs DiseaseAmyloid beta-ProteinAnti-Retroviral AgentsAreaBiological MarkersBlood VesselsC-reactive proteinCD4 Lymphocyte CountCerebrovascular DisordersCertificationChronicChronic DiseaseClinicalClinical ResearchClinical TrialsCohort StudiesCollaborationsCommunity Health EducationComorbidityConsultationsDataData AnalysesDepositionDevelopmentDiagnosticDisciplineDiseaseDistalDistantDrug FormulationsDyslipidemiasEffectivenessEligibility DeterminationEnrollmentEpidemicEquilibriumEquipmentEquipment and SuppliesEquipment and supply inventoriesEvaluationEventExposure toExtramural ActivitiesFundingFutureGeneticGenomicsGenotypeHIVHIV InfectionsHeadHuman ResourcesImageImmuneImmune responseImpairmentIndividualInfectionInflammationInjuryInstitutionInsulin ResistanceInterdisciplinary StudyInternationalInvestigationLaboratoriesLeadLinkLipidsMacrophage ActivationMalariaMeasurementMeasuresMedical HistoryMeningitisMentorshipMetabolic DiseasesMethodsMorbidity - disease rateNerve DegenerationNervous system structureNeurobiologyNeurocognitiveNeurodegenerative DisordersNeurologicNeurovirologyOutcomeParticipantPathogenesisPathway interactionsPatientsPenetrationPharmacologyPhenotypePhysical ExaminationPilot ProjectsPopulationPredispositionPrevalencePreventionProcessProteinsPublicationsRecording of previous eventsRecoveryResearchResearch InfrastructureResearch MethodologyResearch PersonnelResearch Project GrantsResearch SupportResourcesRiskRisk FactorsRoleSamplingScientific EvaluationSecureSpinal PunctureStagingTeleconferencesTestingTrainingTranslational ResearchTranslationsTuberculosisUpdateValidationVascular DiseasesViralViral Load resultViral PhysiologyViral hepatitisVirusVirus DiseasesWorkage relatedantiretroviral therapybaseclinically relevantcytokinedevelopmental neurobiologydisabilityflexibilityimmune activationinnovationinterdisciplinary collaborationmeetingsmortalitynerve injurynervous system disorderneurobehavioralneurobehavioral disorderneuroimagingneurotoxicnovelnovel strategiespathogenpreventprogramspublic health prioritiesrepositorysample collectionsensory neuropathystatisticstool developmenttransmission processvirus geneticsvirus host interactionvolunteer
项目摘要
Advances in antiretroviral therapy have reduced but not eliminated mortality and neurologic morbidity
related to HIV infection. The epidemic has been transformed into a chronic disease in which there is a
dynamic equilibrium between mechanisms maintaining viral persistence and host immune strategies that,
in combination with antiretroviral therapy, hold viral activity in check. Prospects for eradication or cure are
many years or decades away. Looking toward the future, the HNRC perceives four general areas in which
research needs are greatest. In the renewal period, the Neuromedical Core (NMC) will therefore develop
and mature its research infrastructure to support studies addressing the themes of aging, acute and early
HIV infection and clinical relevance. A common thread linking these three themes is genetics-both host
and viral.
The newly-organized NMC is made up of two cooperative units comprising common resources
(equipment, supplies) and staff that interact on a daily basis: a Clinical Research Support Unit (CRSU); and
a Laboratory, Pharmacology & Biomarker Unit (LPBU). Together these units will perform evaluations on all
HIV+ subjects and HIV- controls, including those enrolled in pilot studies of the Developmental Core. The
over-arching objectives of the Neuromedical Core (NMC) are to provide comprehensive clinical and
laboratory evaluations, scientific consultation, and mentorship, training, and community education in
NeuroAIDS. In the current funding period the NMC facilitated 70 research projects including observational
cohort studies, clinical-pathological investigations, imaging studies, clinical trials and international research
performed by collaborating investigators at UCSD and many other institutions.
By assisting investigators in widely diverging disciplines at all levels of project development, from
conceptualization of hypotheses to study implementation, analysis, interpretation and dissemination, the
NMC encourages the application of multiple scientific perspectives and stimulates interdisciplinary
collaboration and coordination. Through a variety of flexible mechanisms including face-to-face meetings
and video teleconferences we will collaborate closely with the Neuroimaging, Neurobehavioral,
Neurovirology, Neurobiology, Developmental and International Cores to further the HNRC's
transdisciplinary aims.
抗逆转录病毒疗法的进步降低了但没有消除死亡率和神经系统发病率
与HIV感染有关。该流行病已转化为一种慢性疾病,其中有一个
保持病毒持久性的机制和宿主免疫策略之间的动态平衡,这些策略
结合抗逆转录病毒疗法,检查病毒活性。根除或治愈的前景是
多年或几十年之遥。着眼于未来,HNRC感知到了四个一般领域
研究需求是最大的。因此,在续签期间,神经医学核心(NMC)将发展
并成熟其研究基础设施,以支持针对衰老,急性和早期主题的研究
HIV感染和临床相关性。链接这三个主题的一个共同线程是遗传主机
和病毒。
新组织的NMC由两个合作单元组成,包括共同资源
(设备,用品)和每天互动的员工:临床研究支持单位(CRSU);和
实验室,药理学和生物标志物(LPBU)。这些单元将共同执行所有人的评估
HIV+受试者和HIV控制,包括参加发育核心试验研究的受试者。这
神经医学核心(NMC)的整个目标是提供全面的临床和
实验室评估,科学咨询以及指导,培训和社区教育
神经辅助。在当前的资助期内,NMC促进了70个研究项目,包括观察
队列研究,临床病理研究,成像研究,临床试验和国际研究
由UCSD和许多其他机构的调查人员合作进行。
通过协助调查人员在项目开发的各个层面上广泛分歧的学科,
假设的概念化以研究实施,分析,解释和传播,
NMC鼓励应用多种科学观点并刺激跨学科
协作与协调。通过各种灵活的机制,包括面对面的会议
和视频电视会议我们将与神经影像,神经行为密切合作,
神经病毒学,神经生物学,发展和国际核心,以进一步进一步HNRC
跨学科的目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RONALD J. ELLIS其他文献
RONALD J. ELLIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RONALD J. ELLIS', 18)}}的其他基金
GPLD1: Association with Cognition and Amelioration through Exercise in Aging People with HIV
GPLD1:老年艾滋病毒感染者通过运动与认知和改善的关系
- 批准号:
10403225 - 财政年份:2022
- 资助金额:
$ 35.35万 - 项目类别:
CHARTER Plus: A resource for cutting-edge research on neurological function and mental health in people with HIV and substance use disorders across the lifespan
CHARTER Plus:艾滋病毒感染者和药物使用障碍患者整个生命周期神经功能和心理健康的前沿研究资源
- 批准号:
10557157 - 财政年份:2022
- 资助金额:
$ 35.35万 - 项目类别:
GPLD1: Association with Cognition and Amelioration through Exercise in Aging People with HIV
GPLD1:老年艾滋病毒感染者通过运动与认知和改善的关系
- 批准号:
10687143 - 财政年份:2022
- 资助金额:
$ 35.35万 - 项目类别:
Effects of Cannabidiol and Tetrahydrocannabinol on the Microbiome, Endocannabinoids and Neuroinflammation in HIV
大麻二酚和四氢大麻酚对 HIV 微生物组、内源性大麻素和神经炎症的影响
- 批准号:
10463371 - 财政年份:2022
- 资助金额:
$ 35.35万 - 项目类别:
Effects of Cannabidiol and Tetrahydrocannabinol on the Microbiome, Endocannabinoids and Neuroinflammation in HIV
大麻二酚和四氢大麻酚对 HIV 微生物组、内源性大麻素和神经炎症的影响
- 批准号:
10634642 - 财政年份:2022
- 资助金额:
$ 35.35万 - 项目类别:
CHARTER Plus: A resource for cutting-edge research on neurological function and mental health in people with HIV and substance use disorders across the lifespan
CHARTER Plus:艾滋病毒感染者和药物使用障碍患者整个生命周期神经功能和心理健康的前沿研究资源
- 批准号:
10403811 - 财政年份:2022
- 资助金额:
$ 35.35万 - 项目类别:
Immunometabolicgene expression profiles associated with depressed mood and behavioral domains inpeople with HIV
与艾滋病毒感染者抑郁情绪和行为领域相关的免疫代谢基因表达谱
- 批准号:
10369973 - 财政年份:2021
- 资助金额:
$ 35.35万 - 项目类别:
Immunometabolicgene expression profiles associated with depressed mood and behavioral domains inpeople with HIV
与艾滋病毒感染者抑郁情绪和行为领域相关的免疫代谢基因表达谱
- 批准号:
10487532 - 财政年份:2021
- 资助金额:
$ 35.35万 - 项目类别:
Immunometabolicgene expression profiles associated with depressed mood and behavioral domains inpeople with HIV
与艾滋病毒感染者抑郁情绪和行为领域相关的免疫代谢基因表达谱
- 批准号:
10643884 - 财政年份:2021
- 资助金额:
$ 35.35万 - 项目类别:
Biopsychosocial Phenotypes and Potential Mechanisms in CHARTER
CHARTER 中的生物心理社会表型和潜在机制
- 批准号:
10706855 - 财政年份:2020
- 资助金额:
$ 35.35万 - 项目类别:
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
- 批准号:22304039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
- 批准号:82300173
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
- 批准号:82360957
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:地区科学基金项目
相似海外基金
The role of transcription factors and chromatin remodeling proteins in spiral ganglion neuron regeneration
转录因子和染色质重塑蛋白在螺旋神经节神经元再生中的作用
- 批准号:
9009399 - 财政年份:2016
- 资助金额:
$ 35.35万 - 项目类别:
The role of transcription factors and chromatin remodeling proteins in spiral ganglion neuron regeneration
转录因子和染色质重塑蛋白在螺旋神经节神经元再生中的作用
- 批准号:
9917756 - 财政年份:2016
- 资助金额:
$ 35.35万 - 项目类别:
The role of transcription factors and chromatin remodeling proteins in spiral ganglion neuron regeneration
转录因子和染色质重塑蛋白在螺旋神经节神经元再生中的作用
- 批准号:
9480008 - 财政年份:2016
- 资助金额:
$ 35.35万 - 项目类别:
Opiate induced SIV-Neuropathogenesis: Role of miRNA-29b in the Periphery-CNS Cro
阿片诱导的 SIV 神经发病机制:miRNA-29b 在外周 CNS Cro 中的作用
- 批准号:
8476570 - 财政年份:2013
- 资助金额:
$ 35.35万 - 项目类别: